%D8%BA%D9%84%D9%88%D9%83%D8%A7%D8%BA%D9%88%D9%86Ql%C3%BCkaqon%D0%93%D0%BB%D1%8E%D0%BA%D0%B0%D0%B3%D0%BE%D0%BD%D0%93%D0%BB%D1%8E%D0%BA%D0%B0%D0%B3%D0%BE%D0%BD%E0%A6%97%E0%A7%8D%E0%A6%B2%E0%A7%81%E0%A6%95%E0%A6%BE%E0%A6%97%E0%A6%A8GlukagonGlucag%C3%B3GlukagonGCGGlukagonGlucagon%DE%8E%DE%B0%DE%8D%DE%AB%DE%86%DE%A6%DE%8E%DE%AE%DE%82%DE%B0%CE%93%CE%BB%CF%85%CE%BA%CE%B1%CE%B3%CF%8C%CE%BD%CE%B7GlucagonGlukagonoGlucag%C3%B3nGlukagoi%DA%AF%D9%84%D9%88%DA%A9%D8%A7%DA%AF%D9%88%D9%86GlukagoniGlucagonGl%C3%BAcag%C3%B3nGlicag%C3%B3n%D7%92%D7%9C%D7%95%D7%A7%D7%92%D7%95%D7%9FGlukagonGlukagon%D4%B3%D5%AC%D5%B5%D5%B8%D6%82%D5%AF%D5%A1%D5%A3%D5%B8%D5%B6GlukagonGl%C3%BAkagonGlucagone%E3%82%B0%E3%83%AB%E3%82%AB%E3%82%B4%E3%83%B3%D0%93%D0%BB%D1%8E%D0%BA%D0%B0%D0%B3%D0%BE%D0%BD%EA%B8%80%EB%A3%A8%EC%B9%B4%EA%B3%A4Glukagon%D0%93%D0%BB%D1%8E%D0%BA%D0%B0%D0%B3%D0%BE%D0%BDGlucagonGliukagonas%D0%93%D0%BB%D1%83%D0%BA%D0%B0%D0%B3%D0%BE%D0%BD%E0%A4%97%E0%A5%8D%E0%A4%B2%E0%A5%81%E0%A4%95%E0%A5%85%E0%A4%97%E0%A5%89%E0%A4%A8GlukagonGlucagon
about
Natriuretic Effect of GLP-1in Healthy Non Obese SubjectsThe Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart FailureCardioprotective Effects of GLP-1 and Their MechanismsGLP-1 Loading During Elective Percutaneous Coronary InterventionHepatic Metabolic Changes in Response to Glucagon InfusionInvestigation of GLP-2 Mechanism of ActionThe Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During HypoglycemiaProtein, Amino Acids & Insulin & Glucagon Secretion in HumansThe Effect of GLP-1 on the Inhibition of Glucagon SecretionEffectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) FailureDiet Oil Induced Stimulation of GLP-1Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) TherapyThe Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion InjuryGut Hormone Response After Paleolithic-type MealsAssessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesEfficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsInvestigating the Incretin Effect in Cystic FibrosisSafety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe HypoglycemiaGlucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)Intranasal Glucagon and Energy BalanceGlucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric SurgeryA Study Comparing User Experience of Different Delivery Devices for GlucagonG-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesThe Effects of Neprilysin on Glucagon-like Peptide-1Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male SubjectsImproving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical TrialsGlucagon's Cardiovascular Effects With and Without Beta-blocker-induced CardioinhibitionGlucagon-like Peptide-1 Metabolism and Acute Neprilysin InhibitionDoes Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy VolunteersExploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult MenSafety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureSafety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaFLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)Artificial Pancreas Control System in an Inpatient SettingThe Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesEffects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in DiabetesMechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
P4844
cellular response to glucagon stimulusresponse to glucagonglucagon receptor activityglucagon bindingglucagon processingmature GLP-1mature GLP-1 [plasma membrane]GCGR:GCG(53-81)mature GLP-1 [secretory granule lumen]GLP-1 (Cleaved at N-terminus)GLP2R:GCG(146-178)Ligands of GPCRs that activate GsLigands of GPCRs that activate Gq/11Glucagon binds to Glucagon receptorAcyl Ghrelin and C-Ghrelin are secretedSynthesis of Preproglucagon in intestinal L cellsSignal peptidase hydrolyzes preproGLP-1 to proGLP-1Proglucagon translocates from the ER Lumen to secretory granulesPCSK1 hydrolyzes Proglucagon to Glucagon-like Peptide-1Glucagon-like receptor 2 binds GLP2Glucagon
P527
P688
Modulation of β-catenin signaling by glucagon receptor activation.Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeoverMinireview: Glucagon in stress and energy homeostasis.Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance.Dynamic monitoring of glucagon secretion from living cells on a microfluidic chip.Glucagon regulates ACC activity in adipocytes through the CAMKKβ/AMPK pathway.Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.Isolated mouse islets respond to glucose with an initial peak of glucagon release followed by pulses of insulin and somatostatin in antisynchrony with glucagon.Impaired crosstalk between pulsatile insulin and glucagon secretion in prediabetic individuals.Functional and structural adaptations in the pancreatic α-cell and changes in glucagon signaling during protein malnutrition.Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattleArterial stimulation and venous sampling for glucagonomas of the pancreas
P921
description
chemická sloučenina
@cs
chemische stof
@nl
component quimic
@oc
compost químic
@ca
composto chimico
@it
composto químico
@gl
composto químico
@pt
composto químico
@pt-br
composé chimique
@fr
compuesto quimico
@an
name
GCG
@cy
Glicagón
@gl
Gliukagonas
@lt
Glucagon
@de
Glucagon
@fr
Glucagon
@la
Glucagon
@nl
Glucagon
@oc
Glucagon
@pam
Glucagon
@pt
type
label
GCG
@cy
Glicagón
@gl
Gliukagonas
@lt
Glucagon
@de
Glucagon
@fr
Glucagon
@la
Glucagon
@nl
Glucagon
@oc
Glucagon
@pam
Glucagon
@pt
altLabel
GCG(53-81)
@en
Glucagon
@ar
Glucagon
@ca
Glucagon
@en
Glucagon
@es
Glucagon
@sv
Glucagon
@th
Glucágon
@pt
Glukagon
@de
Glükagon
@tr
prefLabel
GCG
@cy
Glicagón
@gl
Gliukagonas
@lt
Glucagon
@de
Glucagon
@fr
Glucagon
@la
Glucagon
@nl
Glucagon
@oc
Glucagon
@pam
Glucagon
@pt